mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.057 |
0.8 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |